RecruitingNCT05937594
MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome
Studying Rare developmental defect during embryogenesis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Milton S. Hershey Medical Center
- Principal Investigator
- Steven D. Hicks, MD, PhDAssociate Professor of Pediatrics
- Intervention
- Buccal swab saliva for further genetic testing(genetic)
- Enrollment
- 50 target
- Eligibility
- All sexes
- Timeline
- 2020 – 2027
Study locations (1)
- Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Collaborators
National Institute on Drug Abuse (NIDA)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05937594 on ClinicalTrials.govOther trials for Rare developmental defect during embryogenesis
Additional recruiting or active studies for the same condition.
See all trials for Rare developmental defect during embryogenesis →